Related references
Note: Only part of the references are listed.Cytidine deaminases APOBEC3G and APOBEC3F interact with human immunodeficiency virus type 1 integrase and inhibit proviral DNA formation
Kun Luo et al.
JOURNAL OF VIROLOGY (2007)
Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G: A possible role in the resistance to HIV of HIV-exposed seronegative individuals
Mara Biasin et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
APOBEC3G levels predict rates of progression to AIDS
Xia Jin et al.
RETROVIROLOGY (2007)
Effect of genetic variants of CCR2 and CCL2 on the natural history of HIV-1 infection -: CCL2-2518GG is overrepresented in a cohort of Spanish HIV-1-infected subjects
Consuelo Vilades et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2007)
Biochemical differentiation of APOBEC3F and APOBEC3G proteins associated with HIV-1 life cycle
Xiaojun Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
High expression of APOBEC3G in patients infected with hepatitis C virus
Yoshihiro Komohara et al.
JOURNAL OF MOLECULAR HISTOLOGY (2006)
Population level analysis of human immunodeficiency virus type 1 hypermutation and its relationship with APOBEC3G and vif genetic variation
Craig Pace et al.
JOURNAL OF VIROLOGY (2006)
Elevations in IL-10, TNF-α, and IFN-γ from the earliest point of HIV type 1 infection
Philip J. Norris et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2006)
Alpha interferon potently enhances the anti-human immunodeficiency virus type I activity of APOBEC3G in resting primary CD4 T cells
Keyang Chen et al.
JOURNAL OF VIROLOGY (2006)
Differential expression of IFN-α and TRAIL/DR5 in lymphoid tissue of progressor versus nonprogressor HIV-1-infected patients
JP Herbeuval et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Anti-viral protein APOBEC3G is induced by interferon-α stimulation in human hepatocytes
Y Tanaka et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
APOBEC3F and APOBEC3G mRNA levels do not correlate with human immunodeficiency virus type 1 plasma viremia or CD4+ T-cell count
SJ Cho et al.
JOURNAL OF VIROLOGY (2006)
Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti-HIV-1 activity
G Peng et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Polymorphism of RANTES chemokine gene promoter is not associated with long-term nonprogressive HIV-1 infection of more than 16 years
F Vidal et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2006)
Spanish HIV-1-infected long-term nonprogressors of more than 15 years have an increased frequency of the CX3CR1 2491 variant allele
F Vidal et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2005)
APOBEC3G/CEM15 (hA3G) mRNA levels associate inversely with human immunodeficiency virus viremia
X Jin et al.
JOURNAL OF VIROLOGY (2005)
Low human immunodeficiency virus envelope diversity correlates with low in vitro replication capacity and predicts spontaneous control of plasma viremia after treatment interruptions
B Joos et al.
JOURNAL OF VIROLOGY (2005)
Role of viral evolutionary rate in HIV-1 disease progression in a linked cohort
M Mikhail et al.
RETROVIROLOGY (2005)
被撤回的出版物: Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells (Retracted Article. See vol 466, pg 276, 2010)
YL Chiu et al.
NATURE (2005)
The retroviral hypermutation specificity of APOBEC3F and APOBEC3G is governed by the C-terminal DNA cytosine deaminase domain
G Haché et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Comparison of the differential context-dependence of DNA deamination by APOBEC enzymes:: Correlation with mutation spectra in vivo
RCL Beale et al.
JOURNAL OF MOLECULAR BIOLOGY (2004)
APOBEC3F properties and hypermutation preferences indicate activity against HIV-1 in vivo
MT Liddament et al.
CURRENT BIOLOGY (2004)
Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication
YH Zheng et al.
JOURNAL OF VIROLOGY (2004)
Amino-terminal region of the human immunodeficiency virus type 1 nucleocapsid is required for human APOBEC3G packaging
K Luo et al.
JOURNAL OF VIROLOGY (2004)
Retroviral restriction by APOBEC proteins
RS Harris et al.
NATURE REVIEWS IMMUNOLOGY (2004)
Rapid clearance of virus after acute HIV-1 infection: Correlates of risk of AIDS
WA Blattner et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex
XH Yu et al.
SCIENCE (2003)
Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts
B Mangeat et al.
NATURE (2003)
The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA
H Zhang et al.
NATURE (2003)
HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation
M Marin et al.
NATURE MEDICINE (2003)
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein
AM Sheehy et al.
NATURE (2002)
An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22
A Jarmuz et al.
GENOMICS (2002)
Human immunodeficiency virus type 1 DNA sequences genetically damaged by hypermutation are often abundant in patient peripheral blood mononuclear cells and may be generated during near-simultaneous infection and activation of CD4+ T cells
M Janini et al.
JOURNAL OF VIROLOGY (2001)
Share Paper
